PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns.

Platelet-derived growth factor (PDGF)-BB is a well-known smooth muscle (SM) cell (SMC) phenotypic modulator that signals by binding to PDGF alphaalpha-, alphabeta-, and betabeta-membrane receptors. PDGF-DD is a recently identified PDGF family member, and its role in SMC phenotypic modulation is unknown. Here we demonstrate that PDGF-DD inhibited expression of multiple SMC genes, including SM alpha-actin and SM myosin heavy chain, and upregulated expression of the potent SMC differentiation repressor gene Kruppel-like factor-4 at the mRNA and protein levels. On the basis of the results of promoter-reporter assays, changes in SMC gene expression were mediated, at least in part, at the level of transcription. Attenuation of the SMC phenotypic modulatory activity of PDGF-DD by pharmacological inhibitors of ERK phosphorylation and by a small interfering RNA to Kruppel-like factor-4 highlight the role of these two pathways in this process. PDGF-DD failed to repress SM alpha-actin and SM myosin heavy chain in mouse SMCs lacking a functional PDGF beta-receptor. Importantly, PDGF-DD expression was increased in neointimal lesions in the aortic arch region of apolipoprotein C-deficient (ApoE(-/-)) mice. Furthermore, human endothelial cells exposed to an atherosclerosis-prone flow pattern, as in vascular regions susceptible to the development of atherosclerosis, exhibited a significant increase in PDGF-DD expression. These findings demonstrate a novel activity for PDGF-DD in SMC biology and highlight the potential contribution of this molecule to SMC phenotypic modulation in the setting of disturbed blood flow.

[1]  C. Betsholtz,et al.  Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. , 2002, The American journal of pathology.

[2]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[3]  Johanna Andrae,et al.  Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.

[4]  Ronald M. Lauer,et al.  National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health. , 1991, Archives of internal medicine.

[5]  U. Eriksson,et al.  The PDGF family: four gene products form five dimeric isoforms. , 2004, Cytokine & growth factor reviews.

[6]  G. Owens,et al.  Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. , 1989, The American journal of physiology.

[7]  M. Schwartz,et al.  Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis , 2007, The Journal of cell biology.

[8]  M. Jeffers,et al.  Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer. , 2002, Cancer research.

[9]  Da-Zhi Wang,et al.  Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression , 2004, Nature.

[10]  G. Owens,et al.  Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. , 2004, American journal of physiology. Heart and circulatory physiology.

[11]  C. Heldin,et al.  PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor , 2001, Nature Cell Biology.

[12]  E. Anggard,et al.  Endogenously elicited antibodies to platelet derived growth factor‐BB and platelet cytosolic protein inhibit aortic lesion development in the cholesterol‐fed rabbit , 1997, International journal of experimental pathology.

[13]  B. Rauch,et al.  Platelet-Derived Growth Factor-BB–Induced Human Smooth Muscle Cell Proliferation Depends on Basic FGF Release and FGFR-1 Activation , 2005, Circulation research.

[14]  M. Peach,et al.  Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. , 1992, Circulation research.

[15]  G. Owens,et al.  Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. , 2007, American journal of physiology. Cell physiology.

[16]  M. Davies,et al.  Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.

[17]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[18]  Sanjay Sinha,et al.  Kruppel-like Factor 4 Abrogates Myocardin-induced Activation of Smooth Muscle Gene Expression* , 2005, Journal of Biological Chemistry.

[19]  G. Owens,et al.  Platelet‐derived growth factor regulates actin isoform expression and growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells , 1990, Journal of cellular physiology.

[20]  K. Cunningham,et al.  The role of shear stress in the pathogenesis of atherosclerosis , 2005, Laboratory Investigation.

[21]  K. Sobue,et al.  Changes in the Balance of Phosphoinositide 3-Kinase/Protein Kinase B (Akt) and the Mitogen-activated Protein Kinases (ERK/p38MAPK) Determine a Phenotype of Visceral and Vascular Smooth Muscle Cells , 1999, The Journal of cell biology.

[22]  O. McDonald,et al.  A G/C Element Mediates Repression of the SM22&agr; Promoter Within Phenotypically Modulated Smooth Muscle Cells in Experimental Atherosclerosis , 2004, Circulation research.

[23]  M. Davies,et al.  Effect of Platelet-Derived Growth Factor Receptor-α and -β Blockade on Flow-Induced Neointimal Formation in Endothelialized Baboon Vascular Grafts , 2000 .

[24]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[25]  O. McDonald,et al.  5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. , 2005, The Journal of clinical investigation.

[26]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[27]  K. Pietras,et al.  Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice , 2005, Circulation research.

[28]  O. McDonald,et al.  Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. , 2005, The Journal of clinical investigation.

[29]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[30]  H. Kim,et al.  Platelet-Derived Growth Factor D Is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma Cells , 2005, Molecular and Cellular Biology.

[31]  Z. Galis,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[32]  R. Virmani,et al.  Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction , 1998, Heart.

[33]  G. Owens,et al.  Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. , 2007, American journal of physiology. Cell physiology.

[34]  C. Zarins,et al.  Carotid Bifurcation Atherosclerosis: Quantitative Correlation of Plaque Localization with Flow Velocity Profiles and Wall Shear Stress , 1983, Circulation research.

[35]  O. McDonald,et al.  Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. , 2007, American journal of physiology. Cell physiology.

[36]  R. Schroter,et al.  Atheroma and arterial wall shear - Observation, correlation and proposal of a shear dependent mass transfer mechanism for atherogenesis , 1971, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[37]  J. Rothberg,et al.  PDGF-D, a new protease-activated growth factor , 2001, Nature Cell Biology.

[38]  C. Heldin,et al.  Different Effects of High and Low Shear Stress on Platelet-Derived Growth Factor Isoform Release by Endothelial Cells: Consequences for Smooth Muscle Cell Migration , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[39]  B. Gelfand,et al.  Spatial and spectral heterogeneity of time‐varying shear stress profiles in the carotid bifurcation by phase‐contrast MRI , 2006, Journal of magnetic resonance imaging : JMRI.

[40]  H. Inui,et al.  Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis. , 1994, The Journal of biological chemistry.

[41]  P. Phillips,et al.  Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. , 1989, The Journal of biological chemistry.

[42]  Philippe Soriano,et al.  Roles of PDGF in animal development , 2003, Development.

[43]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[44]  Yan Liu,et al.  A Transforming Growth Factor-β Control Element Required for SM α-Actin Expression in Vivo Also Partially Mediates GKLF-dependent Transcriptional Repression* , 2003, Journal of Biological Chemistry.